Cite Filings / TCRT / 0001193125-19-003789

Feed Companies Filings Check

Sign in

8-K

Current Report

Alaunos Therapeutics, Inc. Filed 2019-01-07 Acc 0001193125-19-003789

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , d687534d8k.htm

Around this filing

2019-01-10 8-K Executive or director change · Regulation FD disclosure
2019-01-08 4 SVP, Treasurer & CAO acquired 37,122 shares (grant or award)
2019-01-08 4 General Counsel and Secretary acquired 117,572 shares (grant or award)
2019-01-08 4 Chief Executive Officer gave up 165,178 shares (to pay taxes)
2019-01-08 4 President acquired 159,010 shares (grant or award)
2019-01-07 8-K Regulation FD disclosure
2018-12-14 8-K Executive or director change

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d687534d8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…